High-dose methotrexate, thiotepa, orelabrutinib combined with or without rituximab in primary or secondary central nervous system diffuse large B-cell lymphoma: a single-center retrospective analysis

Purpose: Central nervous system lymphoma (CNSL) is an aggressive non-Hodgkin's lymphoma (NHL) confined to the central nervous system (CNS). Orelabrutinib is an oral second-generation Bruton tyrosine kinase (BTK) inhibitor and a novel therapeutic strategy for CNSL. The purpose of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yufeng, Li, Yajun, Zeng, Ruolan, He, Yizi, Liang, Liang, Ou, Lijia, Su, Chang, Zhou, Hui, Xiao, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622989/
https://www.ncbi.nlm.nih.gov/pubmed/37928429
http://dx.doi.org/10.7150/jca.85756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622989/
https://www.ncbi.nlm.nih.gov/pubmed/37928429
http://dx.doi.org/10.7150/jca.85756

Ejemplares similares